Literature DB >> 18460888

Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells.

Tetsuo Shiohara1, Yoshiko Mizukawa, Ryo Takahashi, Yoko Kano.   

Abstract

Lichen planus (LP) is an idiopathic inflammatory disease of the skin and mucous membranes, characterized by an autoimmune attack on the epidermis by skin-infiltrating T cells. It remains unknown, however, how such autoaggressive T cells could be activated in vivo to cause epidermal damage; we hypothesize that memory T cells specific for a previously encountered virus could cross-react with other antigens, including contact allergens, drugs and other heterologous viruses in the absence of cognate antigen, and cause epidermal damage. This hypothesis provides an explanation for an intimate relationship between exposure to a number of exogenous agents, such as viruses and drugs, and the development of LP. In addition to T cells migrating from the circulation, T cells indigenously residing in the epidermis, such as intraepidermal CD8+ T cells, would also be involved in tissue damage. This population is typically detected at high frequencies in the resting lesion of fixed drug eruption, which is a simplified disease model for LP. Fucosyltransferase VII, essential for generating E-selectin ligand, is shown to play an indispensable role in inducing the accumulation of relevant skin-homing T cells at sites of LP lesions; however, the alternative notion should be appreciated that T cell recruitment to the skin is also crucial for host defense and that T cells frequently found in LP lesions could display beneficial properties for the host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460888     DOI: 10.1159/000131456

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  6 in total

1.  [Involvement of mucous membranes in papulosquamous diseases].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

2.  The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients.

Authors:  Gui-Xiang Liu; Qi Xie; Cheng-Jun Zhou; Xiao-Ying Zhang; Bo-Long Ma; Cheng-Qin Wang; Feng-Cai Wei; Xun Qu; Shan-Zhen Sun
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

Review 3.  Morphologic features of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Huaibin M Ko; Juan C Hernandez-Prera; Hongfa Zhu; Steven H Dikman; Harleen K Sidhu; Stephen C Ward; Swan N Thung
Journal:  Clin Dev Immunol       Date:  2012-08-05

4.  Atypical clinical presentation of lichen planus bullous in a systemic sclerosis patient.

Authors:  Zofia A Gerlicz-Kowalczuk; Jolanta D Torzecka; Marek Kot; Bożena Dziankowska-Bartkowiak
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

5.  Oral lichen planus after COVID-19, a case report.

Authors:  Wafaa Saleh; Eman SHawky; Ghady Abdel Halim; Fatma Ata
Journal:  Ann Med Surg (Lond)       Date:  2021-11-11

6.  Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination.

Authors:  Zeinab Aryanian; Kamran Balighi; Arghavan Azizpour; Kambiz Kamyab Hesari; Parvaneh Hatami
Journal:  Case Rep Dermatol Med       Date:  2022-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.